HMOX1: A pivotal regulator of prognosis and immune dynamics in ovarian cancer
HMOX1 emerges as a critical therapeutic target, intricately involved in immunomodulation, prognosis, and the malignant behavior of ovarian cancer. This highlights HMOX1 as a potential biomarker and therapeutic target in the fight against ovarian cancer.
Authors
- Jinfa Huang (ORCID: https://orcid.org/0000-0001-5557-8924)
- Ruiwan Tan
Institutions
- The First People's Hospital of Shunde (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- BMC Women s Health
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1186/s12905-024-03309-3
- Citations
- 8
- Primary Topic
- Genomics, phytochemicals, and oxidative stress
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- Southern Medical University